The role of αβ- and γδ-T cells in allogeneic donor marrow on engraftment, chimerism, and graft-versus-host disease

被引:28
|
作者
Huang, YM
Cramer, DE
Ray, MB
Chilton, PM
Que, XY
Ildstad, ST
机构
[1] Univ Louisville, Inst Cellular Therapeut, Louisville, KY 40202 USA
[2] Univ Louisville, Dept Pathol, Louisville, KY 40202 USA
关键词
D O I
10.1097/00007890-200112270-00007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. We previously characterized a facilitating cell (FC) in mouse marrow that enables engraftment of allogeneic hematopoietic stem cells (HSCs) without causing graft-versus-host disease (GVHD). The FC shares some cell surface molecules with T cells (Thy1(+), CD3epsilon(+), CD8(+), CD5(+), and CD2(+)) but is T-cell receptor (TCR) negative. Historically, depletion of CD3(+) or CD8(+) cells from rat marrow was associated with an increased rate of failure of engraftment. In this study, we evaluated whether depletion of alphabeta- and gammadelta-TCR+ T cells from donor marrow would retain engraftment potential yet avoid GVHD. Methods. Wistar-Furth rats were conditioned with 950 cGy of total body irradiation and transplanted with ACI bone marrow processed to remove either alphabeta-TCR+, gammadelta-TCR+, or alphabeta- plus gammabeta-TCR+ T cells. Recipients were typed for chimerism at 28 days and monthly thereafter. Results. Recipients of marrow depleted of alphabeta- (group A), gammadelta- (group B), or alphabeta- and gammadelta-TCR+ T cells (group C) engrafted and had an average chimerism level of 73.0 +/- 8.3%, 92.3 +/- 9.2%, and 46.3 +/- 32.8%, respectively. Aggressive T-cell depletion did not remove the FC population (CD8(+)/CD3(+)/TCR-). Group A and group B both developed GVHD, with a higher incidence of GVHD in group B compared to group A. None of the recipients in group C developed GVHD. Conclusions. These data demonstrate that depletion of T cells from rat marrow does not impair engraftment of HSCs, indirectly supporting the existence of FCs in rat marrow. Moreover, donor alphabeta- and gammadelta-TCR+ T cells contribute to GVHD in a nonredundant fashion, although alphabeta-TCR+ T cells are more potent as the effector cells. Finally, the level of donor chimerism is influenced by the composition of the graft, because recipients of marrow that contain alphabeta-TCR+ T cells exhibited significantly higher donor chimerism compared to recipients of marrow depleted of both alphabeta- and gammadelta-TCR+ T cells.
引用
收藏
页码:1907 / 1914
页数:8
相关论文
共 50 条
  • [41] GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    YOSHIKAWA, S
    AKAO, Y
    HIRAIWA, A
    SAO, H
    YAMAUCHI, T
    TAHARA, T
    YOSHIKAWA, H
    MATSUYAMA, K
    KIMURA, S
    KITAYAMA, S
    TANABE, S
    UNO, H
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1984, 14 : 509 - 518
  • [42] GRAFT-VERSUS-HOST DISEASE IN EXPERIMENTAL ALLOGENEIC BONE-MARROW TRANSPLANTATION
    KORNGOLD, R
    SPRENT, J
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1991, 197 (01): : 12 - 18
  • [43] Role of dendritic cells in graft-versus-host disease
    Clark, FJ
    Chakraverty, R
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2002, 11 (04): : 601 - 616
  • [44] GRAFT-VERSUS-HOST DISEASE - HOST AND DONOR VIEWS
    DEEG, HJ
    SEMINARS IN HEMATOLOGY, 1993, 30 (04) : 110 - 118
  • [45] Role of endothelial cells in graft-versus-host disease
    Neidemire-Colley, Lotus
    Robert, Jeremy
    Ackaoui, Antoine
    Dorrance, Adrienne. M. M.
    Guimond, Martin
    Ranganathan, Parvathi
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [46] Host T cells affect donor T cell engraftment and graft-versus-host disease after reduced-intensity hematopoietic stem cell transplantation
    Hardy, Nancy M.
    Hakim, Frances
    Steinberg, Seth M.
    Krumlauf, Michael
    Cvitkovic, Romana
    Babb, Rebecca
    Odom, Feanne
    Fowler, Daniel H.
    Gress, Ronald E.
    Bishop, Michael R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (09) : 1022 - 1030
  • [47] Graft-versus-host disease in allogeneic bone marrow transplantation: the role of monoclonal antibodies in prevention and treatment
    Hiscott, A
    McLellan, DS
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2000, 57 (02) : 163 - 169
  • [48] INFLUENCE OF THE CONDITIONING REGIMEN ON ERYTHROCYTE CHIMERISM, GRAFT-VERSUS-HOST DISEASE AND RELAPSE AFTER ALLOGENEIC TRANSPLANTATION WITH LYMPHOCYTE DEPLETED MARROW
    BAR, BMAM
    SCHATTENBERG, A
    DEMAN, AJM
    HOOGENHOUT, J
    BOEZEMAN, J
    DEWITTE, T
    BONE MARROW TRANSPLANTATION, 1992, 10 (01) : 45 - 52
  • [49] POOR GRAFT FUNCTION ASSOCIATED WITH GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION
    PERALVO, J
    BACIGALUPO, A
    PITTALUGA, PA
    OCCHINI, D
    VANLINT, MT
    FRASSONI, F
    NARDELLI, E
    TRASINO, A
    PANTAROTTO, M
    MARMONT, AM
    BONE MARROW TRANSPLANTATION, 1987, 2 (03) : 279 - 285
  • [50] EXCELLENT ENGRAFTMENT WITHOUT GRAFT-VERSUS-HOST DISEASE OR VENOOCCLUSIVE DISEASE IN T-CELL DEPLETED SIBLING MATCHED ALLOGENEIC BONE-MARROW TRANSPLANT
    RIGDEN, J
    CORNETTA, K
    BAUTE, J
    BROUN, ER
    CUNNINGHAM, I
    HEDDERMAN, A
    HROMAS, R
    MENKE, C
    RUBIN, L
    SROUR, EF
    TRICOT, G
    BLOOD, 1994, 84 (10) : A720 - A720